Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
HOXB cluster antisense RNA 4 (HOXB-AS4) is a human long non-coding RNA (lncRNA) transcribed from the HOXB gene cluster on chromosome 17. It does not encode a protein and is part of a class of natural antisense transcripts (NATs) found at HOX clusters, which are known to regulate the expression of adjacent HOX genes through epigenetic mechanisms such as methylation. HOXB-AS4 has been identified as displaying differential DNA methylation in normal versus pancreatic cancer cells, suggesting a potential role in cancer-specific gene regulation and as a putative biomarker for cancer. Its precise biological functions and mechanisms are not characterized in detail, and there is no evidence it is a direct receptor, enzyme, or transporter, nor that it currently serves as a direct therapeutic target[2][3][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on HOXB cluster antisense RNA 4 (HOXB-AS4).